The Relationship Between Chronic OA Pain and Cognition Deficits in OA Patients.
1 other identifier
observational
60
1 country
1
Brief Summary
The goal of this observational study is to learn about the association between pain characteristics and cognitive functions in chronic knee osteoarthritis. The main questions it aims to answer are:
- 1.If pain characteristics affect cognitive functions in severe knee OA patients?
- 2.If concentration of neuroinflammation mediators were raised in severe knee OA patients with comparing with control group participants?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 21, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 22, 2021
CompletedFirst Submitted
Initial submission to the registry
October 4, 2022
CompletedFirst Posted
Study publicly available on registry
October 6, 2022
CompletedOctober 6, 2022
October 1, 2022
1.7 years
October 4, 2022
October 4, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
The Western Ontario and McMaster universities Osteoarthritis Index (WOMAC)
The WOMAC questionnaire has been used to assess subjects with OA of the hip or knee and consists of 24 items divided into 3 subscales: self-perception of pain (5 items), joint stiffness (2 items), and functional performance (17 items) during the previous 72 h.
The WOMAC questionnaire were measured on the day before their surgery.
The cognitive abilities screening instrument (CASI)
The CASI has been commonly used in dementia research and clinical practice to evaluate a subject's cognitive abilities.
The CASI questionnaire were measured on the day before their surgery.
Glia mediators of neuroinflammation
Glia mediators of neuroinflammation include interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor α (TNF α), BDNF and fractalkine.
All blood and CSF samples were obtained before spinal anesthesia.
Secondary Outcomes (1)
The geriatric depression scale (GDS-15)
The GDS-15 questionnaire were measured on the day before their surgery.
Study Arms (2)
OA group
Knee osteoarthritis patients who were scheduled to receive elective total knee replacement surgery which need spinal anesthesia.
Control group
Control group patients were scheduled to receive elective general surgery or urological surgery with spinal anesthesia.
Eligibility Criteria
People with chronic knee osteoarthritis pain who will receive total knee replacement surgery. They have no other chronic pain except chronic knee pain. Furthermore they did not have any cerebral diseases such as stroke or brain tumor.
You may qualify if:
- OA patients who were scheduled to receive elective surgery which need spinal anesthesia.
- Age is more than 20 years old.
- American Society of Anesthesiologists (ASA) class I-III.
You may not qualify if:
- Unwilling to participate.
- Age is lesser than 20 years old.
- Autoimmune diseases.
- Previous knee injury or infection history.
- Brain region disease ex: stroke or brain tumor...etc.
- Mild cognitive impairment, dementia or other neurodegenerative diseases.
- Cancer.
- With other chronic pain.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kaohsiung Veterans General Hopital
Kaohsiung City, Zuoying Dist, 813414, Taiwan
Related Publications (12)
Zhang Y, Jordan JM. Epidemiology of osteoarthritis. Clin Geriatr Med. 2010 Aug;26(3):355-69. doi: 10.1016/j.cger.2010.03.001.
PMID: 20699159RESULTKyrkanides S, Tallents RH, Miller JN, Olschowka ME, Johnson R, Yang M, Olschowka JA, Brouxhon SM, O'Banion MK. Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice. J Neuroinflammation. 2011 Sep 7;8:112. doi: 10.1186/1742-2094-8-112.
PMID: 21899735RESULTHuang SW, Wang WT, Chou LC, Liao CD, Liou TH, Lin HW. Osteoarthritis increases the risk of dementia: a nationwide cohort study in Taiwan. Sci Rep. 2015 May 18;5:10145. doi: 10.1038/srep10145.
PMID: 25984812RESULTLi X, Tong Q, Gao J, Liu C; Alzheimer's Disease Neuroimaging Initiative; Liu Y. Osteoarthritis Was Associated With a Faster Decline in Hippocampal Volumes in Cognitively Normal Older People. Front Aging Neurosci. 2020 Aug 14;12:190. doi: 10.3389/fnagi.2020.00190. eCollection 2020.
PMID: 32922280RESULTWu L, Wang X, Ye Y, Liu C. Association of Osteoarthritis With Changes in Structural Neuroimaging Markers Over Time Among Non-demented Older Adults. Front Aging Neurosci. 2021 Aug 10;13:664443. doi: 10.3389/fnagi.2021.664443. eCollection 2021.
PMID: 34447303RESULTClark AK, Malcangio M. Fractalkine/CX3CR1 signaling during neuropathic pain. Front Cell Neurosci. 2014 May 7;8:121. doi: 10.3389/fncel.2014.00121. eCollection 2014.
PMID: 24847207RESULTGrace PM, Hutchinson MR, Maier SF, Watkins LR. Pathological pain and the neuroimmune interface. Nat Rev Immunol. 2014 Apr;14(4):217-31. doi: 10.1038/nri3621. Epub 2014 Feb 28.
PMID: 24577438RESULTMontague K, Malcangio M. The therapeutic potential of targeting chemokine signalling in the treatment of chronic pain. J Neurochem. 2017 May;141(4):520-531. doi: 10.1111/jnc.13927. Epub 2017 Feb 24.
PMID: 27973687RESULTSubbarayan MS, Joly-Amado A, Bickford PC, Nash KR. CX3CL1/CX3CR1 signaling targets for the treatment of neurodegenerative diseases. Pharmacol Ther. 2022 Mar;231:107989. doi: 10.1016/j.pharmthera.2021.107989. Epub 2021 Sep 4.
PMID: 34492237RESULTCappoli N, Tabolacci E, Aceto P, Dello Russo C. The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception. J Neuroimmunol. 2020 Dec 15;349:577406. doi: 10.1016/j.jneuroim.2020.577406. Epub 2020 Sep 24.
PMID: 33002723RESULTMalfait AM, Miller RE, Block JA. Targeting neurotrophic factors: Novel approaches to musculoskeletal pain. Pharmacol Ther. 2020 Jul;211:107553. doi: 10.1016/j.pharmthera.2020.107553. Epub 2020 Apr 18.
PMID: 32311372RESULTTang J, Bair M, Descalzi G. Reactive Astrocytes: Critical Players in the Development of Chronic Pain. Front Psychiatry. 2021 May 28;12:682056. doi: 10.3389/fpsyt.2021.682056. eCollection 2021.
PMID: 34122194RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chun-Hsien Wen, Physician
Kaohsiung Veterans General Hospital.
- STUDY DIRECTOR
Chen-Hsiu Chen, Physician
Kaohsiung Veterans General Hospital.
- STUDY DIRECTOR
Yuan-Yi Chia, Director
Kaohsiung Veterans General Hospital.
- STUDY CHAIR
Chih-Chi Tsai, RA
Kaohsiung Veterans General Hospital.
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician
Study Record Dates
First Submitted
October 4, 2022
First Posted
October 6, 2022
Study Start
August 7, 2019
Primary Completion
April 21, 2021
Study Completion
April 22, 2021
Last Updated
October 6, 2022
Record last verified: 2022-10